In a multipolar world, power and influence are no longer separate. Their interdependence defines global politics—reshaping alliances, narratives, and the logic of survival.

For decades, international relations scholars distinguished between hard power—military force, economic strength—and soft power—persuasion, culture, legitimacy. Nations were ranked by arsenals and GDP, or by universities and films. Power was material; influence was intangible.
In 2025, this neat division collapses. Power and influence are no longer separable. Influence amplifies power; power without influence corrodes. Militaries require narratives. Economies require trust. Culture requires platforms. Narratives require reach. The interdependence of power and influence defines global politics. Nations that master the fusion rise. Nations that cling to old distinctions decline.
Russia exemplifies power without influence. Its arsenal is vast, its resources immense. Yet its narratives ring hollow. Its propaganda persuades few beyond those already aligned. Its alliances are transactional, brittle. Power without influence breeds isolation. Bombs frighten but do not inspire. Tanks invade but do not legitimise. Without influence, power is feared but unsustainable.
The twenty-first century punishes those who wield power without narrative. Europe often exemplifies influence without power. Its culture is admired. Its regulatory models are emulated. Its diplomacy is respected. Yet its hard power is limited. Militaries lag. Dependence on energy imports exposes fragility.
Influence without power risks irrelevance. Norms inspire, but without capacity to enforce, they wither. Values persuade, but without deterrence, they invite challenge. Influence alone cannot defend survival. It must be anchored in power.

The United States still demonstrates the fusion of both. Its military is unmatched. Its economy remains vast. Its culture dominates globally through film, music, technology. Its narratives—though contested—still resonate. Yet America’s challenge is internal. Polarisation erodes legitimacy. Influence declines when democracy falters. Power declines when alliances doubt credibility.
The U.S. remains strongest when power and influence are aligned. When they diverge, decline accelerates. China seeks to fuse power and influence deliberately. Its Belt and Road Initiative expands economic reach. Its Confucius Institutes project culture. Its digital platforms extend narratives. Its military modernises steadily.
Yet influence remains contested. Trust is limited. Narratives of prosperity are undermined by censorship, repression, and debt traps. China demonstrates that interdependence is strategic, not automatic. Influence must be credible. Power must be restrained. Otherwise, interdependence becomes coercion.

In the twenty-first century, narratives are weapons. Disinformation campaigns shape elections. Memes influence protests. Hashtags mobilise movements.
Influence is no longer passive—it is weaponised. Power without narratives cannot compete. Influence without power cannot survive counterattacks. Interdependence is battlefield. Russia weaponises lies. China weaponises platforms. Democracies weaponise exposure. The struggle is less about territory than attention.
Alliances today depend on interdependence of power and influence. NATO’s strength is not only its arsenal but its narrative of collective defence. The EU’s influence rests not only on regulations but on promise of shared prosperity. When narratives falter, alliances weaken. When arsenals lack legitimacy, alliances fracture.
Interdependence is glue. Without it, allies drift. Influence requires citizens. Power is projected not only by governments but by people. Students abroad, entrepreneurs, artists, athletes—all extend influence. Citizens amplify narratives. Citizens embody legitimacy.
Authoritarian regimes suppress citizens, weakening influence. Democracies empower citizens, strengthening credibility. Yet democracies also risk chaos when misinformation divides. Citizens are force multipliers—but also vulnerabilities. Interdependence depends on their trust.
At its core, the interdependence of power and influence raises moral questions. Is it ethical to manipulate narratives for strategic gain? Is persuasion without transparency legitimate? Nations that ignore morality risk hollow influence. Nations that abuse power erode trust. The strongest are those who align morality with strategy—whose power defends values, whose influence reflects authenticity. Without morality, interdependence corrodes into coercion.
The interdependence of power and influence in global politics matters because it defines survival in the twenty-first century. Nations rise or fall not on power alone, not on influence alone, but on their fusion.
This still matters because alliances, citizens, and legitimacy depend on interdependence. Power without influence isolates. Influence without power evaporates. Together, they define not only strategy but civilisation’s future.
The question is not whether nations possess power or influence. The question is whether they can sustain both—interdependent, credible, moral—before fragmentation makes survival itself uncertain.
Anonymous is a private guest contributor of WTM MEDIA. Through Why These Matter, they examines the intersections of ethics, geo-politics, and government leadership—bringing clarity to issues that shape people, influence culture, and determine the future of global society.

The modern city has spent more than a century attempting to make water disappear. Rain falls onto roofs, roads and pavements. Gutters collect it. Drains capture it. Pipes bury it. Pumps move it. Rivers are channelled. Wetlands are filled. Coastlines are defended. The engineering objective has largely been straightforward: separate water from urban life as efficiently as possible. That model is reaching its limits. Around 600 million urban residents already live with significant annual flood hazard, according to the World Bank. Globally, 1.81 billion people live in flood-prone areas, while annual urban flood losses could approach $50 billion by 2050. Rapid urbanisation, ageing drainage infrastructure, land subsidence and changing rainfall patterns are interacting with the basic physical reality that cities have covered enormous portions of naturally absorbent ground with concrete and asphalt. Yet the consequential story is not simply that cities need bigger drains. A different philosophy of urban resilience is emerging: parks designed to flood temporarily; streets shaped to carry cloudbursts; wetlands restored as infrastructure; plazas capable of storing stormwater; permeable landscapes that absorb rainfall; buildings elevated or adapted to tolerate inundation; sensors that reveal water movement in real time; and neighbourhoods organised around the understanding that some water cannot — and perhaps should not — be engineered away. The World Bank increasingly describes effective urban flood management as an integration of grey infrastructure, green infrastructure, nature-based systems, planning, warning systems and institutional reform, rather than reliance on any single engineering intervention. The conceptual reversal is enormous. For generations, successful urbanisation meant controlling nature sufficiently to construct the city. The next generation of urbanism may require something more intelligent: designing the city so nature can still function inside it.

For much of the post-financial-crisis era, wealthy economies became accustomed to an extraordinary condition: money was cheap. Governments could borrow heavily, companies could finance expansion at modest rates, asset prices could rise on abundant liquidity, and households learned to treat low-cost mortgages as something approaching economic normality. That world is disappearing fast. Across major economies, long-term government borrowing costs have climbed towards levels not seen for years or decades. On 17 August, the US 30-year Treasury yield reached roughly 5.31 per cent, its highest level since 2007. Japan’s 10-year government bond yield subsequently approached 2.95 per cent, a three-decade high, while German borrowing costs have risen to 15-year highs. The OECD describes the present combination of elevated financing requirements and elevated yields as exceptional compared with the previous two decades. Behind those numbers is a larger structural contest. Governments need capital for debt refinancing, defence, infrastructure, pensions, healthcare and climate resilience. Technology companies require extraordinary sums for artificial-intelligence infrastructure. Energy systems require grids, generation and storage. Businesses require investment. Families require mortgages and credit. These demands do not occupy separate universes. They ultimately encounter the same fundamental economic resource: capital. And when many powerful institutions want more of it simultaneously, the price of money stops being an obscure financial-market variable. It becomes a question of who gets financed, at what price, and at whose expense.

For more than a century, the word vaccine has largely meant prevention: teach the immune system to recognise a threat before disease takes hold. Cancer is forcing medicine to reconsider that architecture. A new generation of experimental therapies is attempting something considerably more individual: sequence a patient’s tumour, identify mutations particular to that cancer, manufacture instructions corresponding to selected tumour-specific targets, and teach the patient’s immune system to recognise what belongs to the cancer growing inside that particular body. On 19 August, Moderna and Merck announced that their Phase III trial of the investigational personalised mRNA therapy intismeran autogene, used with Merck’s checkpoint inhibitor Keytruda after surgery for high-risk melanoma, achieved statistically significant and clinically meaningful improvements in recurrence-free survival and distant-metastasis-free survival compared with Keytruda alone. The global trial enrolled 1,137 patients with resected stage IIB–IV melanoma. No new safety concerns were identified in the announcement. Full detailed Phase III results remain pending. The result matters because this is not simply another medicine administered to everyone carrying the same diagnosis. Intismeran is designed individually. Tumour and normal tissue are sequenced; mutations are analysed computationally; selected neoantigens — abnormal molecular features produced by the tumour — become the targets encoded into an mRNA therapy manufactured for that patient. Earlier Phase IIb evidence provides important context rather than a substitute for the unreleased Phase III detail. At five-year median follow-up, Moderna and Merck reported that intismeran plus Keytruda reduced the risk of recurrence or death by 49 per cent and distant metastasis or death by 59 per cent compared with Keytruda alone in that smaller study. The larger significance therefore extends beyond melanoma. Medicine has spent generations classifying disease so that patients with sufficiently similar conditions can receive sufficiently similar treatments. Personalised cancer vaccines suggest a different possibility: the diagnosis may identify the disease, while the tumour itself helps design the medicine. If that model succeeds across cancers, one of medicine’s great industrial achievements — standardisation — will begin coexisting with its apparent opposite: manufacturing treatment for one.